Personalised Adaptive Medicine
The PERAMEDIC project aims to develop a desktop-sized system for personalized polypill formulation using 3D printing and precise dosing to enhance treatment outcomes and patient adherence.
Projectdetails
Introduction
Personalised drug formulation is a hot topic, but state-of-the-art approaches are limited by low scalability, cost, and regulatory hurdles. Current polypill formulation efforts are hindered by liquid form or hot melt addition approaches, posing stability issues.
Societal Impact
These bottlenecks carry a great societal price, as the synergic boost of drug combinations was recently demonstrated to reach significant improvement in treatment outcomes. Keeping active substances in the ideal physiological concentration window is known to maximize efficiency and reduce side effects.
Additionally, polypharmacy is a real problem leading to:
- Dosing errors
- Significant loss in patient adherence
Technological Challenges
While Big Data Health IT system concepts on the far horizon hold potential to gather the large amount of reliable dosage-patient data required for evidence-based personalised medicine, the technology to deliver such data is missing. This includes well-tracked patient/dosing procedures with bi-directional digital information flow.
Proposed Solution
The PERAMEDIC project proposes to resolve these problems with a breakthrough solution: a stand-alone drug formulation system for personalised medicine. This system will offer:
- Locally prepared, individually customised, segmented release polypills
- An inherently digital technology interface
Technology Integration
The system relies on integrating several novel technologies:
- Personal release profiles
- In situ 3D printing of release matrix using adaptive toolpaths
- Ultra-precise multichannel powder dosing of drugs into sealed microcompartments
The envisaged device would be a desktop-size pill/capsule printing machine, using canisters of powdered drugs and bioresorbable polymer matrix material.
Application Scenarios
Application scenarios would include:
- First clinical settings
- Later stages at pharmacy locations
- Medical practices such as GP’s offices
Project Outcome
PERAMEDIC will deliver a lab-scale proof-of-concept prototype system of the functionally combined novel technologies, along with a preview design of the future technology.
Financiële details & Tijdlijn
Financiële details
Subsidiebedrag | € 1.726.876 |
Totale projectbegroting | € 1.726.876 |
Tijdlijn
Startdatum | 1-2-2024 |
Einddatum | 31-1-2027 |
Subsidiejaar | 2024 |
Partners & Locaties
Projectpartners
- FRAUNHOFER GESELLSCHAFT ZUR FORDERUNG DER ANGEWANDTEN FORSCHUNG EVpenvoerder
- BULKAI TANACSADO KFT
- ATS ADVISORY SRL
- UNIVERSITY OF EAST ANGLIA
- LOUGHBOROUGH UNIVERSITY
Land(en)
Vergelijkbare projecten binnen EIC Pathfinder
Project | Regeling | Bedrag | Jaar | Actie |
---|---|---|---|---|
"Creation of innovative ""humidity to electricity"" renewable energy conversion technology towards sustainable energy challenge"The CATCHER project aims to develop scalable technology for converting atmospheric humidity into renewable electricity, enhancing EU leadership in clean energy innovation. | EIC Pathfinder | € 2.996.550 | 2022 | Details |
Quantitative Ultrasound Stochastic Tomography - Revolutionizing breast cancer diagnosis and screening with supercomputing-based radiation-free imaging.The project aims to revolutionize breast cancer imaging by developing adjoint-based algorithms for uncertainty quantification, enhancing diagnostic confidence through high-resolution, radiation-free images. | EIC Pathfinder | € 2.744.300 | 2022 | Details |
Dynamic Spatio-Temporal Modulation of Light by Phononic ArchitecturesDynamo aims to revolutionize imaging technologies by enabling simultaneous light modulation at GHz rates, enhancing processing speed and positioning Europe as a leader in optical advancements. | EIC Pathfinder | € 2.552.277 | 2022 | Details |
Emerging technologies for crystal-based gamma-ray light sourcesTECHNO-CLS aims to develop novel gamma-ray light sources using oriented crystals and high-energy particle beams, enhancing applications in various scientific fields through innovative technology. | EIC Pathfinder | € 2.643.187 | 2022 | Details |
"Creation of innovative ""humidity to electricity"" renewable energy conversion technology towards sustainable energy challenge"
The CATCHER project aims to develop scalable technology for converting atmospheric humidity into renewable electricity, enhancing EU leadership in clean energy innovation.
Quantitative Ultrasound Stochastic Tomography - Revolutionizing breast cancer diagnosis and screening with supercomputing-based radiation-free imaging.
The project aims to revolutionize breast cancer imaging by developing adjoint-based algorithms for uncertainty quantification, enhancing diagnostic confidence through high-resolution, radiation-free images.
Dynamic Spatio-Temporal Modulation of Light by Phononic Architectures
Dynamo aims to revolutionize imaging technologies by enabling simultaneous light modulation at GHz rates, enhancing processing speed and positioning Europe as a leader in optical advancements.
Emerging technologies for crystal-based gamma-ray light sources
TECHNO-CLS aims to develop novel gamma-ray light sources using oriented crystals and high-energy particle beams, enhancing applications in various scientific fields through innovative technology.
Vergelijkbare projecten uit andere regelingen
Project | Regeling | Bedrag | Jaar | Actie |
---|---|---|---|---|
Foldable, REconfigurable & Jagged devices for enhanced drug Absorption/seedingThe project aims to develop Self-configurable, Proximity Enabling Devices (SPEDs) for efficient oral delivery of protein/peptide drugs by enhancing retention and interaction with the intestinal wall. | ERC ADG | € 2.556.251 | 2022 | Details |
Enabling patient specific medicines using 3D printing in hospitals and pharmaciesCurifyLabs aims to finalize a standard process for 3D printing personalized medicines using MiniLab technology, enabling scalable, high-quality customization in pharmacies. | EIC Accelerator | € 2.479.750 | 2023 | Details |
MED-MIXDoser B.V. ontwikkelt de MED-MIX om het meng- en vulproces van MED-CARTRIDGES te automatiseren, waardoor gepersonaliseerde medicatie efficiënter en foutlozer geproduceerd kan worden. | MIT Haalbaarheid | € 20.000 | 2023 | Details |
MED-PACKDoser B.V. ontwikkelt MED-PRINT en MED-PACK, een innovatieve 3D-print- en verpaktechnologie voor gepersonaliseerde medicatie, die het verpakproces vereenvoudigt en fouten vermindert. | MIT Haalbaarheid | € 20.000 | 2022 | Details |
Foldable, REconfigurable & Jagged devices for enhanced drug Absorption/seeding
The project aims to develop Self-configurable, Proximity Enabling Devices (SPEDs) for efficient oral delivery of protein/peptide drugs by enhancing retention and interaction with the intestinal wall.
Enabling patient specific medicines using 3D printing in hospitals and pharmacies
CurifyLabs aims to finalize a standard process for 3D printing personalized medicines using MiniLab technology, enabling scalable, high-quality customization in pharmacies.
MED-MIX
Doser B.V. ontwikkelt de MED-MIX om het meng- en vulproces van MED-CARTRIDGES te automatiseren, waardoor gepersonaliseerde medicatie efficiënter en foutlozer geproduceerd kan worden.
MED-PACK
Doser B.V. ontwikkelt MED-PRINT en MED-PACK, een innovatieve 3D-print- en verpaktechnologie voor gepersonaliseerde medicatie, die het verpakproces vereenvoudigt en fouten vermindert.